Exact Mass: 658.3353

Exact Mass Matches: 658.3353

Found 38 metabolites which its exact mass value is equals to given mass value 658.3353, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Methylcellulose

2-{[4,5-dimethoxy-2-(methoxymethyl)-6-{[4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-3,4,5-trimethoxy-6-(methoxymethyl)oxane

C29H54O16 (658.3412)

(4R,9beta,16alpha,24S)-20-hydroxy-9,10,14-trimethyl-1,11,22-trioxo-16,24-epoxy-4,9-cyclo-9,10-secochloesta-2,5,25-trien-2-yl beta-D-glucopyranoside|16alpha,24alpha-epoxy-2,20beta-dihydroxy-3,11,22-trioxo-cucurbita-1,5,25-triene 2-O-beta-D-glucopyranoside|colocynthin A

(4R,9beta,16alpha,24S)-20-hydroxy-9,10,14-trimethyl-1,11,22-trioxo-16,24-epoxy-4,9-cyclo-9,10-secochloesta-2,5,25-trien-2-yl beta-D-glucopyranoside|16alpha,24alpha-epoxy-2,20beta-dihydroxy-3,11,22-trioxo-cucurbita-1,5,25-triene 2-O-beta-D-glucopyranoside|colocynthin A

C36H50O11 (658.3353)

Maltotriose, permethyl

C29H54O16 (658.3412)

gamma-Truxilline

C38H46N2O8 (658.3254)

reveromycin H

C36H50O11 (658.3353)

12-(2-Methylbutanoyl),1,11-di-Ac,Me ester-1,3,7,11,12-Pentahydroxy-14-meliacen-28-oic acid|18-nor-4alpha-carbomethoxy-11beta-acetoxy-12alpha-(2-methylbutanoyloxy)-14,15-deoxyhavanensin-1-acetate

C36H50O11 (658.3353)

C29H54O16

C29H54O16 (658.3412)

24S-hydroxycholesterol 3-sulfate, 24-D-glucuronide

(24S)-cholest-5-en-3beta,24-diol 3-sulfate 24-D-glucuronide

C33H54O11S (658.3387)

3-di(propan-2-yl)phosphanylpropyl-di(propan-2-yl)phosphane,palladium

C30H68P4Pd (658.3306)

methyl cellulose

C29H54O16 (658.3412)

(1,3,4-OXADIAZOLE-2,5-DIYL)BIS(4,1-PHENYLENE) BIS(4-HEPTYLBENZOATE)

C42H46N2O5 (658.3407)

Coco alkyl amines

C38H46N2O8 (658.3254)

Naquotinib mesylate

C31H46N8O6S (658.3261)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

Glc2Me3Me4Me6Me(b1-4)Glc2Me3Me6Me(b1-4)Glc2Me3Me6Me(b)-O-Me

C29H54O16 (658.3412)

CID 168511025

C26H46N10O10 (658.3398)

SQMG 24:5

C33H54O11S (658.3387)

PI O-16:0/4:1;O2

C29H55O14P (658.3329)

PI O-20:1;O2

C29H55O14P (658.3329)

NVP-CGM097

C38H47ClN4O4 (658.3286)

NVP-CGM097 is a potent and selective MDM2 inhibitor with IC50 of 1.7±0.1 nM for hMDM2.

(1r,2s,4r,5r,8r,9s,11r)-9-formyl-2-({[(2s,3s,4r,5s,6s)-3-hydroxy-4-{[(2z,5e,7s)-7-hydroxy-2-methyl-4-oxoocta-2,5-dienoyl]oxy}-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

(1r,2s,4r,5r,8r,9s,11r)-9-formyl-2-({[(2s,3s,4r,5s,6s)-3-hydroxy-4-{[(2z,5e,7s)-7-hydroxy-2-methyl-4-oxoocta-2,5-dienoyl]oxy}-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

C36H50O11 (658.3353)

(2e,4s,5s,6e,8e)-10-[(2r,3s,6s,8s,9r)-9-butyl-8-[(1e,3e)-4-carboxy-3-methylbuta-1,3-dien-1-yl]-9-{[(2e)-3-carboxyprop-2-enoyl]oxy}-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

(2e,4s,5s,6e,8e)-10-[(2r,3s,6s,8s,9r)-9-butyl-8-[(1e,3e)-4-carboxy-3-methylbuta-1,3-dien-1-yl]-9-{[(2e)-3-carboxyprop-2-enoyl]oxy}-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C36H50O11 (658.3353)

(1r,9s,10s)-3-hydroxy-6-[(1r,9s,10s,12s)-3-hydroxy-4,12-dimethoxy-17-methyl-13-oxo-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-trien-6-yl]-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

(1r,9s,10s)-3-hydroxy-6-[(1r,9s,10s,12s)-3-hydroxy-4,12-dimethoxy-17-methyl-13-oxo-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-trien-6-yl]-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

C38H46N2O8 (658.3254)

3-hydroxy-6-{3-hydroxy-4,12-dimethoxy-17-methyl-13-oxo-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-trien-6-yl}-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

3-hydroxy-6-{3-hydroxy-4,12-dimethoxy-17-methyl-13-oxo-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-trien-6-yl}-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

C38H46N2O8 (658.3254)

(1r,2s,4r,5r,8r,9s,11r)-9-formyl-2-({[(2r,3s,4s,5r,6r)-3-hydroxy-4-{[(2z,5e)-7-hydroxy-2-methyl-4-oxoocta-2,5-dienoyl]oxy}-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

(1r,2s,4r,5r,8r,9s,11r)-9-formyl-2-({[(2r,3s,4s,5r,6r)-3-hydroxy-4-{[(2z,5e)-7-hydroxy-2-methyl-4-oxoocta-2,5-dienoyl]oxy}-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

C36H50O11 (658.3353)

9-formyl-2-[({3-hydroxy-4-[(7-hydroxy-2-methyl-4-oxoocta-2,5-dienoyl)oxy]-5-methoxy-6-methyloxan-2-yl}oxy)methyl]-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

9-formyl-2-[({3-hydroxy-4-[(7-hydroxy-2-methyl-4-oxoocta-2,5-dienoyl)oxy]-5-methoxy-6-methyloxan-2-yl}oxy)methyl]-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

C36H50O11 (658.3353)

(1s,3z,16r,18e,21s,23s,25s)-25-benzyl-7,8,21,27-tetrahydroxy-10-methoxy-16,23-dimethyl-22-methylidene-2,12-dioxo-26-azapentacyclo[18.7.0.0¹,²⁴.0⁵,¹¹.0⁶,⁹]heptacosa-3,5(11),18,26-tetraene-6-carboximidic acid

(1s,3z,16r,18e,21s,23s,25s)-25-benzyl-7,8,21,27-tetrahydroxy-10-methoxy-16,23-dimethyl-22-methylidene-2,12-dioxo-26-azapentacyclo[18.7.0.0¹,²⁴.0⁵,¹¹.0⁶,⁹]heptacosa-3,5(11),18,26-tetraene-6-carboximidic acid

C38H46N2O8 (658.3254)

25-benzyl-7,8,21,27-tetrahydroxy-10-methoxy-16,23-dimethyl-22-methylidene-2,12-dioxo-26-azapentacyclo[18.7.0.0¹,²⁴.0⁵,¹¹.0⁶,⁹]heptacosa-3,5(11),18,26-tetraene-6-carboximidic acid

C38H46N2O8 (658.3254)

(1s,3z,6s,7r,8s,9r,10r,16r,18e,20r,21s,23s,24r,25s)-25-benzyl-7,8,21,27-tetrahydroxy-10-methoxy-16,23-dimethyl-22-methylidene-2,12-dioxo-26-azapentacyclo[18.7.0.0¹,²⁴.0⁵,¹¹.0⁶,⁹]heptacosa-3,5(11),18,26-tetraene-6-carboximidic acid

(1s,3z,6s,7r,8s,9r,10r,16r,18e,20r,21s,23s,24r,25s)-25-benzyl-7,8,21,27-tetrahydroxy-10-methoxy-16,23-dimethyl-22-methylidene-2,12-dioxo-26-azapentacyclo[18.7.0.0¹,²⁴.0⁵,¹¹.0⁶,⁹]heptacosa-3,5(11),18,26-tetraene-6-carboximidic acid

C38H46N2O8 (658.3254)

methyl (2s,3s,4s,5r,6s)-6-{[(2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-6-{[(2s,3r,4s,5s)-2,4,5,6-tetramethoxyhexan-3-yl]oxy}oxan-3-yl]oxy}-3,4,5-trimethoxyoxane-2-carboxylate

C29H54O16 (658.3412)

(2s)-n-[(1r)-4-carbamimidamido-1-({3-[(2s,5s)-3,6-dihydroxy-5-[3-(n-hydroxyformamido)propyl]-2,5-dihydropyrazin-2-yl]propyl}(hydroxy)carbamoyl)butyl]-5-(n-hydroxyacetamido)-2-[(1-hydroxyethylidene)amino]pentanimidic acid

(2s)-n-[(1r)-4-carbamimidamido-1-({3-[(2s,5s)-3,6-dihydroxy-5-[3-(n-hydroxyformamido)propyl]-2,5-dihydropyrazin-2-yl]propyl}(hydroxy)carbamoyl)butyl]-5-(n-hydroxyacetamido)-2-[(1-hydroxyethylidene)amino]pentanimidic acid

C26H46N10O10 (658.3398)

methyl 6-{[4,5-dimethoxy-2-(methoxymethyl)-6-[(2,4,5,6-tetramethoxyhexan-3-yl)oxy]oxan-3-yl]oxy}-3,4,5-trimethoxyoxane-2-carboxylate

C29H54O16 (658.3412)

9-hydroxy-2,9,11,14,19,19-hexamethyl-6-(prop-1-en-2-yl)-17-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docosa-16,20-diene-8,13,18-trione

C36H50O11 (658.3353)

(1s,2s,4r,6s,9r,10r,11r,14r,15r)-9-hydroxy-2,9,11,14,19,19-hexamethyl-6-(prop-1-en-2-yl)-17-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docosa-16,20-diene-8,13,18-trione

(1s,2s,4r,6s,9r,10r,11r,14r,15r)-9-hydroxy-2,9,11,14,19,19-hexamethyl-6-(prop-1-en-2-yl)-17-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docosa-16,20-diene-8,13,18-trione

C36H50O11 (658.3353)

(1r,2s,4r,5r,8r,9s,11r)-9-formyl-2-({[(2r,3s,4s,5r,6r)-3-hydroxy-4-{[(2z,5e,7s)-7-hydroxy-2-methyl-4-oxoocta-2,5-dienoyl]oxy}-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

(1r,2s,4r,5r,8r,9s,11r)-9-formyl-2-({[(2r,3s,4s,5r,6r)-3-hydroxy-4-{[(2z,5e,7s)-7-hydroxy-2-methyl-4-oxoocta-2,5-dienoyl]oxy}-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

C36H50O11 (658.3353)